Sequential injection-ELISA based system for online determination of hyaluronan

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Immunoassay Development

Background:

• Hyaluronan (HA) is a significant biomarker for liver, bone, and cancer diseases.
• Conventional enzyme-linked immunosorbent assays (ELISA) for HA are time-consuming (5-8 hours).
• Need for automated, rapid, and precise immunoassay systems for clinical diagnostics.

Purpose of the Study:

• To develop an automated sequential injection-bead-based immunoassay system.
• To enhance precision and reduce analysis time for hyaluronan quantification.
• To adapt the system for potential use with human serum samples.

Main Methods:

• Designed a novel manifold for sequential injection to minimize reagent dispersion and back pressure.
• Utilized a computer-controlled bi-directional syringe pump for precise micro-volume delivery and timing.
• Employed a competitive enzyme-linked immunosorbent assay (ELISA) technique with immobilized HA and biotinylated HA-binding proteins (b-HABPs).

Main Results:

• Achieved a lowest detectable concentration of 1 ng/mL HA with a dynamic working range of 1-5000 ng/mL.
• Demonstrated low intra-assay (4-10%) and inter-assay (9-12%) variability.
• Reduced total analysis time to approximately 30 minutes, a significant improvement over conventional ELISA.

Conclusions:

• The developed sequential injection-bead immunoassay system provides a rapid and automated method for HA detection.
• The system's efficiency and reusability of beads (with guanidine washing) offer practical advantages.
• This automated assay shows promise for clinical applications, including HA determination in human serum.